Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

CUSIP: 86150R107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+1,536,191
Put/Call ratio
8.1%
SEC-reported price per share
$31.74
Number of holders
183
Value change
+$58,211,085
Number of buys
96
Open additional details 1 more signal available
Number of sells
70
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,810,778

Security key

86150R107

Report period

Q4 2025

Institutions

183

Top holders

10

Ownership snapshot

Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.8% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 9.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 9.8%
BlackRock, Inc. 6.8%
MORGAN STANLEY 6.5%
BAKER BROS. ADVISORS LP 5.8%
BlackRock Portfolio Management LLC 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
9.8%
$177,773,201
5,600,920 shares
-$40,123,708 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
6.8%
from 13D/G
$140,704,869
5,987,441 shares
30 Sep 2025
MORGAN STANLEY
13F 13D/G
Company
6.5%
from 13D/G
$83,120,676
3,537,050 shares
30 Sep 2025
BAKER BROS. ADVISORS LP
13F 13D/G
Company
5.8%
from 13D/G
$108,895,193
4,633,838 shares
30 Sep 2025
BlackRock Portfolio Management LLC
13D/G
4.7%
$28,946,115
2,550,341 shares
-$2,192,358 30 Jun 2025
Skorpios Trust
13F 13D/G 3/4/5
Company · Montrago Trustees Ltd · 10%+ Owner
4.1%
from 13D/G
$53,020,254
2,256,181 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
183
Shares
66,984,195
Rows available
183
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
151
Q4 2025 holders
183
Holder diff
32
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .